To understand the role of TGIF1 expression in the survival of patients with glioma, we divided the samples derived from the aforementioned databases into high‐ and low‐expression groups based on the median expression level of TGIF1 in the samples and used the Kaplan–Meier method to explore the relationship between this gene's expression and patient survival. The gene discussed is TGIF1; the disease is central nervous system cancer.